Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study

ABSTRACT Background and Aim Combining systemic chemotherapy with transarterial chemoembolization (TACE) has demonstrated improved outcomes, with promising results for the efficacy of lenvatinib pretreatment combined with TACE in single‐arm studies involving patients with hepatocellular carcinoma (HC...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Nobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga, Yukie Nakadai, Takaya Tabuchi, Po‐Sung Chu, Shingo Usui, Hitomi Hoshi, Fumihiko Kaneko, Akihiro Yamaguchi, Jun Koizumi, Hirotoshi Ebinuma, Masashi Tamura, Jitsuro Tsukada, Masanori Inoue, Seishi Nakatsuka, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2026-01-01
Cyfres:	Cancer Medicine
Pynciau:	hepatocellular carcinoma lenvatinib transarterial chemoembolization
Mynediad Ar-lein:	https://doi.org/10.1002/cam4.71503
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!